I’d like to tell you the reason for the rocket-like rise in shares of Eden Energy, but I’ve got nothing. With a rise of $1.36 today to a freakin’ $6.44 close–which was a penny below the day’s high, and almost 3 million shares traded, it’s safe to assume that either this is the mother of all short squeezes, or that somebody thinks they know something. I have no knowledge of either or any news pending. As I said, I got nothin… at the moment.

Makes a dull market interesting, no?

While the Noah exploration play has the potential of an elephant find in the Nevada/Utah basin, drilling doesn’t start until the fall last I heard.

SmallCap brought you Eden at $2.80 a scant 3 months ago. For those who bought around there you’re sitting on a paper gain of roughly 130 percent, already. Mommy.

Tempted to let some go? You’re on your own. We’ll see Monday. Maybe we’ll have some news by then. Or not.
Wild.

Trade Safely.

Data Integrator Informatica has been a good play for those who followed me in–virtually speaking–I don’t own any as that would be a conflict–in late 2004 at $7.48. The shares have had a skookum couple of days and breached $11 this am for a paper return of almost 50 percent. And now? here’s the chart:

Even though the price has moved up nicely, the chart still looks constructive. May well break out to a new high which would be good. If it backs up to $9.50, might be a good entry or exit point depending on your bent. Analyst projection for 06 earnings is 37 cents, which throws off an almost 30 p/e. The company still has $250 million in cash and no debt which mitigates somewhat the rising p/e. That’s almost $3 in cash per share.

Really up to you how to play it. Selling a bit may be good, as you can’t kick a profit. Suspect it will grind around and show some decent trading opportunities. Also the specter of being acquired as we’ve mentioned before although we have no knowledge and those rumors have died down.

Matter of making some decent money now or holding on and potentially making more money.

Nokia on Line two…

I still like Nokia for the reasons stated previously. Unfortunately, the market took it down further and triggered my stop. Still think there’s life in this one, but again, you’ll either have to hold for a longer term or sell it and drive on. Slated to make $1.15 in 06 according to analysts projections. At $15.25 that’s only a 13 p/e. Interesting. I’ll keep an eye on it. You do the same.

Biotech stuff

Later this week we’re going to chat about the biotech sector in the SmallCap. We’ve got a couple of new names one of which we’ll likely roll out next week. This one is truly unique and has some great moves in it in our opinion. best sign up for the newsletter if you haven’t as yet.

By the way, have a boo at the new BioCurex Research Report. For the reasons we’ve been stating for the last 18 months, there’s lots of compelling potential with this cancer diagnostic (and more) biotech. You should likely have some. The shares are acting well and look to want to move higher. Read our previous pieces on the company and decide.

Trade Safely.

Even though Q2 earnings were up 15%, the intelligentsia pounded NOKIA shares due to an apparent slightly weaker outlook for the current quarter. We Alerted the SmallCap readership when the shares were $16.80. Some trading opportunities as the shares hit $18. Tuesday.

We said in our alert that we’d rather buy the shares at $15.50. They got to $15.81 this am. Close enough. here’s the chart:

We’ve had an almost perfect .618 retracement courtesy of this over reaction, in our opinion. It’s time to buy the shares. A stop at $15.49 should hold nicely.

Heres a press report on the Q2 numbers.

Trade Safely.

As I mentioned in today’s SmallCap issue Eden Energy has been either a trader’s dream or nightmare. While we love volatility, we feel that there’s opportunity for the stalwarts among us. Or you hearty types at least.

The shares popped to $4.50-ish Monday and pulled back to around $3.85 right now. Oh, hell, here’s the chart and an excerpt. I also looked at the recent action in BioCurex which stormed to life, albeit briefly, yesterday. Some cool news out today. Read the piece and don’t forget to signup in the upper left corner. You wouldn’t want to miss anything now, would you?

EDNE CHART:

”

Eden Energy (OTCBB: EDNE) shares have, to say the least, had an active few days. After running up to $4.59 on Monday from under $3 last week, the shares pulled back to just under $4 Tuesday and closed the day at $4.24.

Whether the rise is a result of new investor interest, short covering or a combination of both, the action simply means that the shares have decisively popped up on significantly more radar screens. That’s a good thing. Since the 30th of June, the daily share volume has ranged from 800,000 to over 3 million.

We first Alerted the readership to Eden at $2.80 with subsequent accumulation suggestions from $2.50 to $3. The shares were trading at around $4.05-$4.10 at the opening, Wednesday. That’s roughly a 45 percent gain in a scant few weeks. While we are cautious short-term about being aggressive buyers over $4, some exposure is certainly warranted given Eden’s exploration potential, which we have frequently noted here and on the SCBLOG. We would like to see the shares retrace to the .382 or .618 levels as noted on the chart prior to initiating any large new buying—maybe pick up shares at one and more if it gets to the lower end of the retracement range.

At the time of writing this tome, the shares had pulled back to just under $3.80 or within a few cents of that first technical retracement level. Picking up a few shares for risk-oriented investors at these levels might well make sense…”

Oh yes there’s more. Sign up for the newsletter or visit our homepage. I’d really rather you just signed up. Immediately if not sooner…

Other than a recent small equity issue/sale, haven’t seen much on Bottomline Tech. We reiterated our interest in this financial process management company in mid-May when we thought a partial sale around $13.50 made sense. The shares powered past that level and closed Thursday up $1 at a blistering $17.54. We brought this one to y’all at $10.50 in late 2004, so it’s been a nice winner–up about 70 percent in six, seven months. Nice…

The chart looks open to the upside, but I would still let some go to lower your cost base. Given the volatility, you’ll likely get a chance to fill some in at lower prices. Maybe. Probably right to keep some as the mo-mo seems strong and volumes are increasing. Could be a sell on history if there is news pending. Dunno. I merely comment, illumionate and opinionate. The trading is up to y’all.

Faites vos jeux…

Trade safely.

Having lived in the UK for a couple of years, my heart goes out to those affected. Nasty business.

The attack was early in the morning, US time, so the market carnage was pretty much over by the open in NY.

Isonics popped from $3 to $3.60 presumably due to its bomb detection technology. CNBC was all over it and others in the sector as ‘beneficiaries’ of the heightened sensitivities resulting from the London attacks. At least that activity will put it on more investor radar screens. The shares seem to have settled in the $3.35-$3.40 area. It will likely remain volatile while we wait for more news on one or more of the company’s divisions.
Here’s the chart:

Big stocks wobbled slightly, but the opening was merely weak-ish as opposed to a major decline and it seems calm, relatively speaking, has been restored. Gold popped, bonds got volatile as early reaction saw a flight to quality. Most of the jockeying was pre-market. The dow and NAZ opened down, but not really with any more velocity or volatility than normal.

I suspect the markets will return to normalcy quickly, if they haven’t already.

We’re looking harder at oil as the news of production and availability due to storms and Middle East supply issues spike prices, again. Our exploration pick, Eden Energy has acted nicely since we suggested accumulation both here and in the smallcap newsletter. Our latest accumulation level was around $2.55 in late June and the shares have moved nicely on significant volumes to change hands at $3.20, early Thursday. As more companies move into the area, the potential for Eden, in our opinion, remains enormous. As I’ve said, a find near or around Eden’s Noah project in the Utah/Nevada Basin may well be as positive for the shares short-term as results in the later fall from the play itself.

We’ve been on Biophan since this small company traded by appointment at 35 cents in December 2003. Today, the company announced a nifty deal with Boston Scientific which will see the latter make an equity investment and secure a technology license.

BSX will make a $5 million stock investment in BIPH as well as securing a technology license for a $750,000 up front payment as well as royalties and milestone payments. The rest of the details were not disclosed.

“The license agreement covers multiple patents related to Magnetic Resonance Imaging (MRI) safety and image compatibility, and includes both exclusive and non-exclusive product categories.”

Here’s the balance of the release.

The shares were trading at $2.80-ish pre-opening after closing at $2.61, Thursday. We have frequently updated the readership both here and in the SmallCap Digest and suggested accumulation as recently as June 22nd with the shares at $2.50-$2.55 level.

BIPH shares opened Friday on strong volume at $2.94.

It should be an interesting day both for Biophan and those who have shared the vision.